Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.77395621 |
2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.77395621 |
3 | modulation by symbiont of host immune response (GO:0052553) | 6.77395621 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.77395621 |
5 | modulation by symbiont of host defense response (GO:0052031) | 6.77395621 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.77395621 |
7 | neutrophil activation involved in immune response (GO:0002283) | 5.69729064 |
8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.58889805 |
9 | response to peptidoglycan (GO:0032494) | 5.45724425 |
10 | macrophage activation involved in immune response (GO:0002281) | 5.18287595 |
11 | positive regulation of interferon-alpha production (GO:0032727) | 4.96615393 |
12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.79064254 |
13 | regulation of interferon-alpha production (GO:0032647) | 4.69508149 |
14 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.53973959 |
15 | response to host immune response (GO:0052572) | 4.53973959 |
16 | respiratory burst (GO:0045730) | 4.50230394 |
17 | immunoglobulin mediated immune response (GO:0016064) | 4.48511225 |
18 | granulocyte activation (GO:0036230) | 4.32627350 |
19 | response to muramyl dipeptide (GO:0032495) | 4.26548140 |
20 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.21185398 |
21 | microglial cell activation (GO:0001774) | 4.18565528 |
22 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.16423087 |
23 | neutrophil activation (GO:0042119) | 4.15857441 |
24 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.13663825 |
25 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.13312216 |
26 | natural killer cell mediated immunity (GO:0002228) | 4.09910194 |
27 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.09910194 |
28 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.01618105 |
29 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.00854165 |
30 | response to host (GO:0075136) | 4.00854165 |
31 | response to host defenses (GO:0052200) | 4.00854165 |
32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.93323442 |
33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.81322999 |
34 | myeloid cell activation involved in immune response (GO:0002275) | 3.77701249 |
35 | reactive oxygen species biosynthetic process (GO:1903409) | 3.75570202 |
36 | positive regulation of interferon-beta production (GO:0032728) | 3.74416249 |
37 | positive regulation of antigen processing and presentation (GO:0002579) | 3.74297718 |
38 | type I interferon signaling pathway (GO:0060337) | 3.73389941 |
39 | cellular response to type I interferon (GO:0071357) | 3.73389941 |
40 | superoxide anion generation (GO:0042554) | 3.70824891 |
41 | response to type I interferon (GO:0034340) | 3.70473978 |
42 | macrophage activation (GO:0042116) | 3.66614056 |
43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.64332537 |
44 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.54886724 |
45 | positive regulation of mast cell degranulation (GO:0043306) | 3.54886724 |
46 | I-kappaB phosphorylation (GO:0007252) | 3.49887487 |
47 | positive regulation of heat generation (GO:0031652) | 3.49455168 |
48 | detection of molecule of bacterial origin (GO:0032490) | 3.47576674 |
49 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.46827442 |
50 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.44322274 |
51 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.43351457 |
52 | negative regulation of cell killing (GO:0031342) | 3.43351457 |
53 | defense response to protozoan (GO:0042832) | 3.43082562 |
54 | negative regulation of interleukin-17 production (GO:0032700) | 3.40964389 |
55 | positive regulation of interleukin-12 production (GO:0032735) | 3.40311292 |
56 | detection of other organism (GO:0098543) | 3.40123558 |
57 | regulation of chemokine biosynthetic process (GO:0045073) | 3.39920991 |
58 | NIK/NF-kappaB signaling (GO:0038061) | 3.39916292 |
59 | glycosphingolipid catabolic process (GO:0046479) | 3.39810928 |
60 | positive regulation of mast cell activation (GO:0033005) | 3.33640260 |
61 | T-helper 1 type immune response (GO:0042088) | 3.33520751 |
62 | leukocyte mediated cytotoxicity (GO:0001909) | 3.32005652 |
63 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.28878332 |
64 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.28684394 |
65 | regulation of mononuclear cell migration (GO:0071675) | 3.27676145 |
66 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.27000833 |
67 | B cell mediated immunity (GO:0019724) | 3.26895726 |
68 | regulation of mast cell degranulation (GO:0043304) | 3.26333665 |
69 | regulation of macrophage chemotaxis (GO:0010758) | 3.24949211 |
70 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.24878328 |
71 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.23455316 |
72 | neutrophil mediated immunity (GO:0002446) | 3.23353469 |
73 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.22277213 |
74 | regulation of fever generation (GO:0031620) | 3.21044651 |
75 | detection of external biotic stimulus (GO:0098581) | 3.20268529 |
76 | detection of bacterium (GO:0016045) | 3.19633369 |
77 | amino sugar catabolic process (GO:0046348) | 3.15578716 |
78 | cellular response to interferon-beta (GO:0035458) | 3.13712667 |
79 | regulation of antigen processing and presentation (GO:0002577) | 3.12515337 |
80 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.10713054 |
81 | positive regulation of type 2 immune response (GO:0002830) | 3.10628327 |
82 | negative regulation of interleukin-12 production (GO:0032695) | 3.09261857 |
83 | germinal center formation (GO:0002467) | 3.07157723 |
84 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.06409925 |
85 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.06135281 |
86 | cellular extravasation (GO:0045123) | 3.05133439 |
87 | glycolipid catabolic process (GO:0019377) | 3.04970042 |
88 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.03098927 |
89 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.00745568 |
90 | oligosaccharide catabolic process (GO:0009313) | 3.00439043 |
91 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.00386828 |
92 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.00132473 |
93 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.00132473 |
94 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99733515 |
95 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.99520193 |
96 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.98889953 |
97 | positive regulation of B cell differentiation (GO:0045579) | 2.97867649 |
98 | response to interferon-alpha (GO:0035455) | 2.96262796 |
99 | myeloid dendritic cell differentiation (GO:0043011) | 2.96171126 |
100 | myeloid leukocyte activation (GO:0002274) | 2.94667874 |
101 | positive regulation of chemokine production (GO:0032722) | 2.94565292 |
102 | cellular response to zinc ion (GO:0071294) | 2.94474993 |
103 | adenosine receptor signaling pathway (GO:0001973) | 2.93188290 |
104 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.93138503 |
105 | regulation of interleukin-17 production (GO:0032660) | 2.92810426 |
106 | regulation of interleukin-12 production (GO:0032655) | 2.92609270 |
107 | lymphocyte chemotaxis (GO:0048247) | 2.90419903 |
108 | response to protozoan (GO:0001562) | 2.89409363 |
109 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.89378873 |
110 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.89117754 |
111 | positive regulation of leukocyte degranulation (GO:0043302) | 2.88667536 |
112 | regulation of mast cell activation (GO:0033003) | 2.88064353 |
113 | negative regulation of viral genome replication (GO:0045071) | 2.87557399 |
114 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.87447490 |
115 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.86633550 |
116 | cytokine secretion (GO:0050663) | 2.86171264 |
117 | regulation of hypersensitivity (GO:0002883) | 2.83158956 |
118 | detection of biotic stimulus (GO:0009595) | 2.82153542 |
119 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.75283175 |
120 | mannose metabolic process (GO:0006013) | 2.73224095 |
121 | regulation of gamma-delta T cell activation (GO:0046643) | 2.71292989 |
122 | ceramide catabolic process (GO:0046514) | 2.70201282 |
123 | regulation of leukocyte degranulation (GO:0043300) | 2.70140160 |
124 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.68935654 |
125 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.67706660 |
126 | positive regulation of macrophage cytokine production (GO:0060907) | 2.60914976 |
127 | myeloid dendritic cell activation (GO:0001773) | 2.59951286 |
128 | cellular response to interferon-gamma (GO:0071346) | 2.59358683 |
129 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.59203772 |
130 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.59014869 |
131 | regulation of T cell tolerance induction (GO:0002664) | 2.58182405 |
132 | regulation of cholesterol storage (GO:0010885) | 2.54576646 |
133 | response to thyroid hormone (GO:0097066) | 2.49836288 |
134 | dendritic cell differentiation (GO:0097028) | 2.49770386 |
135 | barbed-end actin filament capping (GO:0051016) | 2.48936199 |
136 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.48523175 |
137 | response to interferon-gamma (GO:0034341) | 2.48231586 |
138 | regulation of type 2 immune response (GO:0002828) | 2.47243417 |
139 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.42973282 |
140 | positive regulation of cholesterol efflux (GO:0010875) | 2.41186082 |
141 | regulation of macrophage cytokine production (GO:0010935) | 2.40759338 |
142 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.39950399 |
143 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.39930053 |
144 | peptide catabolic process (GO:0043171) | 2.36999657 |
145 | adhesion of symbiont to host cell (GO:0044650) | 2.36748747 |
146 | virion attachment to host cell (GO:0019062) | 2.36748747 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.49249302 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.40349468 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.07670869 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.78062368 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.44154214 |
6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.40002515 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.32015317 |
8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.90479046 |
9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.85877829 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.38198552 |
11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.29824615 |
12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.05075174 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.03811904 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92315856 |
15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.82391482 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.71303059 |
17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.60522294 |
18 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.40610176 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17890791 |
20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17249792 |
21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.16683785 |
22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14637143 |
23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.11444294 |
24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.91607964 |
25 | SPI1_23127762_ChIP-Seq_K562_Human | 1.85658714 |
26 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.83475360 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80594253 |
28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.78510197 |
29 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76814682 |
30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.76520908 |
31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.74929209 |
32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70308044 |
33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68662224 |
34 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66618662 |
35 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62375736 |
36 | MYB_26560356_Chip-Seq_TH2_Human | 1.62116969 |
37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62029432 |
38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.60408197 |
39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58918780 |
40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58817719 |
41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57202323 |
42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49255427 |
43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48316558 |
44 | * MAF_26560356_Chip-Seq_TH1_Human | 1.46922737 |
45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42379505 |
46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40461418 |
47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37885625 |
48 | MYB_26560356_Chip-Seq_TH1_Human | 1.37413629 |
49 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37173015 |
50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.35085198 |
51 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33617402 |
52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.29861261 |
53 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.28189849 |
54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27011741 |
55 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26321119 |
56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26097491 |
57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25984394 |
58 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24946905 |
59 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.24131184 |
60 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22109443 |
61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20138049 |
62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20056796 |
63 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.17236462 |
64 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16418080 |
65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15436067 |
66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14270205 |
67 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13813275 |
68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12530051 |
69 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11844324 |
70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11515178 |
71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11246143 |
72 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.10634843 |
73 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08228921 |
74 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04025414 |
75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02680582 |
76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98583979 |
77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98005726 |
78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97558052 |
79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95237041 |
80 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95226809 |
81 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.94560434 |
82 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93699061 |
83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92791050 |
84 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90346661 |
85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90327842 |
86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89674724 |
87 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89674724 |
88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87681194 |
89 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87577333 |
90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85995239 |
91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85013144 |
92 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84620165 |
93 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.84308029 |
94 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.82715712 |
95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82562979 |
96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82372925 |
97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82139615 |
98 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.80905547 |
99 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.79364847 |
100 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.79016238 |
101 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77955136 |
102 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.77628786 |
103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76789997 |
104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76789997 |
105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76061605 |
106 | MAF_26560356_Chip-Seq_TH2_Human | 0.74792493 |
107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.73632385 |
108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73367951 |
109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71610361 |
110 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71085590 |
111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69800032 |
112 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.69553946 |
113 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69534073 |
114 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.69364544 |
115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.68100183 |
116 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.67151707 |
117 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66767700 |
118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.66261819 |
119 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.65526144 |
120 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.63823341 |
121 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61763074 |
122 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61183256 |
123 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.60897971 |
124 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.60607387 |
125 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.60607387 |
126 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60574532 |
127 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.60363645 |
128 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.59992442 |
129 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.59672521 |
130 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.56555321 |
131 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.55641865 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.85471981 |
2 | MP0003436_decreased_susceptibility_to | 3.84259834 |
3 | MP0009785_altered_susceptibility_to | 3.77278122 |
4 | MP0003303_peritoneal_inflammation | 3.61899053 |
5 | MP0002148_abnormal_hypersensitivity_rea | 3.55560336 |
6 | MP0002419_abnormal_innate_immunity | 3.37192272 |
7 | MP0006082_CNS_inflammation | 3.30042841 |
8 | MP0005000_abnormal_immune_tolerance | 3.21635072 |
9 | MP0005058_abnormal_lysosome_morphology | 3.20115929 |
10 | MP0005025_abnormal_response_to | 3.03743218 |
11 | MP0005387_immune_system_phenotype | 2.98769666 |
12 | MP0001790_abnormal_immune_system | 2.98769666 |
13 | MP0000685_abnormal_immune_system | 2.87781760 |
14 | MP0002452_abnormal_antigen_presenting | 2.76111495 |
15 | MP0004510_myositis | 2.73405965 |
16 | MP0000569_abnormal_digit_pigmentation | 2.69681447 |
17 | MP0003724_increased_susceptibility_to | 2.65529281 |
18 | MP0001800_abnormal_humoral_immune | 2.59268567 |
19 | MP0002723_abnormal_immune_serum | 2.53707442 |
20 | MP0005671_abnormal_response_to | 2.47392080 |
21 | MP0002139_abnormal_hepatobiliary_system | 2.44933442 |
22 | MP0001819_abnormal_immune_cell | 2.26733492 |
23 | MP0003172_abnormal_lysosome_physiology | 2.23664648 |
24 | MP0002420_abnormal_adaptive_immunity | 2.22030812 |
25 | MP0005464_abnormal_platelet_physiology | 2.14158425 |
26 | MP0001533_abnormal_skeleton_physiology | 2.01338954 |
27 | MP0004947_skin_inflammation | 1.99961612 |
28 | MP0002405_respiratory_system_inflammati | 1.91975477 |
29 | MP0001853_heart_inflammation | 1.91668097 |
30 | MP0009764_decreased_sensitivity_to | 1.89171095 |
31 | MP0003329_amyloid_beta_deposits | 1.87438633 |
32 | MP0001845_abnormal_inflammatory_respons | 1.87224743 |
33 | MP0009278_abnormal_bone_marrow | 1.79192538 |
34 | MP0002006_tumorigenesis | 1.75610735 |
35 | MP0008469_abnormal_protein_level | 1.71444157 |
36 | MP0003075_altered_response_to | 1.71272660 |
37 | MP0003448_altered_tumor_morphology | 1.71088607 |
38 | MP0005310_abnormal_salivary_gland | 1.62905857 |
39 | MP0010155_abnormal_intestine_physiology | 1.60051790 |
40 | MP0000716_abnormal_immune_system | 1.58533789 |
41 | MP0002998_abnormal_bone_remodeling | 1.53753309 |
42 | MP0000343_altered_response_to | 1.53651569 |
43 | MP0003183_abnormal_peptide_metabolism | 1.48469475 |
44 | MP0002398_abnormal_bone_marrow | 1.44662890 |
45 | MP0000604_amyloidosis | 1.43395761 |
46 | MP0005451_abnormal_body_composition | 1.40297572 |
47 | MP0009840_abnormal_foam_cell | 1.36888247 |
48 | MP0005397_hematopoietic_system_phenotyp | 1.35085080 |
49 | MP0001545_abnormal_hematopoietic_system | 1.35085080 |
50 | MP0003191_abnormal_cellular_cholesterol | 1.34550389 |
51 | MP0002166_altered_tumor_susceptibility | 1.33977900 |
52 | MP0009333_abnormal_splenocyte_physiolog | 1.33882796 |
53 | MP0005174_abnormal_tail_pigmentation | 1.32594994 |
54 | MP0005166_decreased_susceptibility_to | 1.28305477 |
55 | MP0000858_altered_metastatic_potential | 1.25396940 |
56 | MP0002429_abnormal_blood_cell | 1.23617659 |
57 | MP0000689_abnormal_spleen_morphology | 1.23416449 |
58 | MP0003690_abnormal_glial_cell | 1.23194332 |
59 | MP0005167_abnormal_blood-brain_barrier | 1.21188199 |
60 | MP0005365_abnormal_bile_salt | 1.20816548 |
61 | MP0008260_abnormal_autophagy | 1.17593839 |
62 | MP0003300_gastrointestinal_ulcer | 1.15728671 |
63 | MP0002254_reproductive_system_inflammat | 1.13084045 |
64 | MP0010307_abnormal_tumor_latency | 1.11080561 |
65 | MP0005076_abnormal_cell_differentiation | 1.08760835 |
66 | MP0002722_abnormal_immune_system | 1.05221668 |
67 | MP0002277_abnormal_respiratory_mucosa | 1.04777898 |
68 | MP0000371_diluted_coat_color | 1.04385547 |
69 | MP0003879_abnormal_hair_cell | 1.04166120 |
70 | MP0003634_abnormal_glial_cell | 1.03332210 |
71 | MP0003279_aneurysm | 1.02066941 |
72 | MP0009763_increased_sensitivity_to | 1.01981326 |
73 | MP0005165_increased_susceptibility_to | 1.00574923 |
74 | MP0005164_abnormal_response_to | 1.00504375 |
75 | MP0002138_abnormal_hepatobiliary_system | 1.00102900 |
76 | MP0008004_abnormal_stomach_pH | 0.99239818 |
77 | MP0000015_abnormal_ear_pigmentation | 0.97788250 |
78 | MP0003828_pulmonary_edema | 0.97460796 |
79 | MP0004858_abnormal_nervous_system | 0.96907498 |
80 | MP0004782_abnormal_surfactant_physiolog | 0.94271294 |
81 | MP0001851_eye_inflammation | 0.91584525 |
82 | MP0005390_skeleton_phenotype | 0.91232319 |
83 | MP0003186_abnormal_redox_activity | 0.87697939 |
84 | MP0008874_decreased_physiological_sensi | 0.84929699 |
85 | MP0003633_abnormal_nervous_system | 0.83493548 |
86 | MP0003806_abnormal_nucleotide_metabolis | 0.81548793 |
87 | MP0001958_emphysema | 0.78210010 |
88 | MP0003656_abnormal_erythrocyte_physiolo | 0.76478049 |
89 | MP0003195_calcinosis | 0.76275169 |
90 | MP0002933_joint_inflammation | 0.75862400 |
91 | MP0005257_abnormal_intraocular_pressure | 0.75722089 |
92 | MP0000249_abnormal_blood_vessel | 0.75466671 |
93 | MP0001542_abnormal_bone_strength | 0.72661844 |
94 | MP0005083_abnormal_biliary_tract | 0.71397923 |
95 | MP0003091_abnormal_cell_migration | 0.71394020 |
96 | MP0003566_abnormal_cell_adhesion | 0.70022215 |
97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69790440 |
98 | MP0005595_abnormal_vascular_smooth | 0.68895216 |
99 | MP0002971_abnormal_brown_adipose | 0.68118368 |
100 | MP0002332_abnormal_exercise_endurance | 0.67667099 |
101 | MP0001501_abnormal_sleep_pattern | 0.66207217 |
102 | MP0004808_abnormal_hematopoietic_stem | 0.66182687 |
103 | MP0006054_spinal_hemorrhage | 0.65990265 |
104 | MP0003632_abnormal_nervous_system | 0.65328692 |
105 | MP0009115_abnormal_fat_cell | 0.65197805 |
106 | MP0003795_abnormal_bone_structure | 0.65196293 |
107 | MP0005535_abnormal_body_temperature | 0.64645859 |
108 | MP0001873_stomach_inflammation | 0.64567087 |
109 | MP0002118_abnormal_lipid_homeostasis | 0.63393522 |
110 | MP0002136_abnormal_kidney_physiology | 0.62953213 |
111 | MP0005023_abnormal_wound_healing | 0.62431899 |
112 | MP0000747_muscle_weakness | 0.61746410 |
113 | MP0003453_abnormal_keratinocyte_physiol | 0.60590869 |
114 | MP0003631_nervous_system_phenotype | 0.60171862 |
115 | MP0005360_urolithiasis | 0.55747483 |
116 | MP0000767_abnormal_smooth_muscle | 0.54469366 |
117 | MP0000490_abnormal_crypts_of | 0.52199449 |
118 | MP0003763_abnormal_thymus_physiology | 0.51837713 |
119 | MP0002090_abnormal_vision | 0.51275262 |
120 | MP0002693_abnormal_pancreas_physiology | 0.50828159 |
121 | MP0004883_abnormal_blood_vessel | 0.49203428 |
122 | MP0001663_abnormal_digestive_system | 0.48578813 |
123 | MP0003045_fibrosis | 0.48101753 |
124 | MP0000465_gastrointestinal_hemorrhage | 0.47476828 |
125 | MP0000920_abnormal_myelination | 0.46900160 |
126 | MP0010386_abnormal_urinary_bladder | 0.46890539 |
127 | MP0003866_abnormal_defecation | 0.45310597 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 7.62933124 |
2 | Recurrent bacterial skin infections (HP:0005406) | 7.21809310 |
3 | Eczematoid dermatitis (HP:0000976) | 7.04810468 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.19767691 |
5 | Mediastinal lymphadenopathy (HP:0100721) | 5.40924037 |
6 | Abnormality of macrophages (HP:0004311) | 5.34472506 |
7 | Increased cerebral lipofuscin (HP:0011813) | 4.63380361 |
8 | Autoimmune thrombocytopenia (HP:0001973) | 4.57655595 |
9 | Vacuolated lymphocytes (HP:0001922) | 4.52014776 |
10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.49591572 |
11 | Systemic lupus erythematosus (HP:0002725) | 4.43091164 |
12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.33260844 |
13 | Recurrent skin infections (HP:0001581) | 4.32311995 |
14 | Gingivitis (HP:0000230) | 4.27486611 |
15 | Orchitis (HP:0100796) | 4.00571300 |
16 | Stomatitis (HP:0010280) | 3.99837816 |
17 | Myositis (HP:0100614) | 3.99510828 |
18 | Optic neuritis (HP:0100653) | 3.91937384 |
19 | Retrobulbar optic neuritis (HP:0100654) | 3.91937384 |
20 | Obstructive lung disease (HP:0006536) | 3.90399242 |
21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.90399242 |
22 | Complement deficiency (HP:0004431) | 3.89478548 |
23 | Recurrent fungal infections (HP:0002841) | 3.88034690 |
24 | Neurofibrillary tangles (HP:0002185) | 3.71436305 |
25 | Mutism (HP:0002300) | 3.70655736 |
26 | Vasculitis (HP:0002633) | 3.68758436 |
27 | Recurrent viral infections (HP:0004429) | 3.54205465 |
28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.38279005 |
29 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.38279005 |
30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.38279005 |
31 | Axonal loss (HP:0003447) | 3.32892340 |
32 | Periodontitis (HP:0000704) | 3.32124624 |
33 | Basal ganglia calcification (HP:0002135) | 3.18259397 |
34 | Prostate neoplasm (HP:0100787) | 3.17304970 |
35 | Increased IgM level (HP:0003496) | 3.16895469 |
36 | Glomerulonephritis (HP:0000099) | 3.15149645 |
37 | Abnormality of complement system (HP:0005339) | 3.14873143 |
38 | Disinhibition (HP:0000734) | 3.09414212 |
39 | Cellulitis (HP:0100658) | 3.04437080 |
40 | Thick nail (HP:0001805) | 3.03889114 |
41 | Pulmonary infiltrates (HP:0002113) | 2.98751837 |
42 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.92681401 |
43 | Dysostosis multiplex (HP:0000943) | 2.92255356 |
44 | Pustule (HP:0200039) | 2.87120353 |
45 | Urticaria (HP:0001025) | 2.86490122 |
46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81359598 |
47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81359598 |
48 | Purpura (HP:0000979) | 2.78215672 |
49 | Meningitis (HP:0001287) | 2.74578801 |
50 | Recurrent pneumonia (HP:0006532) | 2.72395890 |
51 | Osteomyelitis (HP:0002754) | 2.71544590 |
52 | Nuclear cataract (HP:0100018) | 2.70873590 |
53 | Interstitial pulmonary disease (HP:0006530) | 2.70401546 |
54 | Neuronal loss in central nervous system (HP:0002529) | 2.70366291 |
55 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.69582181 |
56 | Hematochezia (HP:0002573) | 2.68018847 |
57 | Tetraparesis (HP:0002273) | 2.65333194 |
58 | Cerebral inclusion bodies (HP:0100314) | 2.60413870 |
59 | Arterial thrombosis (HP:0004420) | 2.55730380 |
60 | Loss of speech (HP:0002371) | 2.53615635 |
61 | Myocardial infarction (HP:0001658) | 2.51614682 |
62 | Leukocytosis (HP:0001974) | 2.51392322 |
63 | Premature loss of primary teeth (HP:0006323) | 2.51206935 |
64 | Chronic otitis media (HP:0000389) | 2.50365356 |
65 | Gastrointestinal infarctions (HP:0005244) | 2.48422736 |
66 | Asymmetric septal hypertrophy (HP:0001670) | 2.44581743 |
67 | Hypergammaglobulinemia (HP:0010702) | 2.43202771 |
68 | Nephritis (HP:0000123) | 2.39307859 |
69 | Hemoptysis (HP:0002105) | 2.39181056 |
70 | Apathy (HP:0000741) | 2.36542338 |
71 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35098719 |
72 | Mucopolysacchariduria (HP:0008155) | 2.35098719 |
73 | Gingival bleeding (HP:0000225) | 2.34884730 |
74 | Recurrent lower respiratory tract infections (HP:0002783) | 2.30237567 |
75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28410596 |
76 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28410596 |
77 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28410596 |
78 | Diminished motivation (HP:0000745) | 2.27652837 |
79 | Bone pain (HP:0002653) | 2.26965292 |
80 | Malnutrition (HP:0004395) | 2.26493943 |
81 | Pathologic fracture (HP:0002756) | 2.22397148 |
82 | Keratoconjunctivitis sicca (HP:0001097) | 2.21665386 |
83 | Increased serum ferritin (HP:0003281) | 2.21183057 |
84 | Hepatosplenomegaly (HP:0001433) | 2.17497348 |
85 | Supranuclear gaze palsy (HP:0000605) | 2.15743830 |
86 | Poor head control (HP:0002421) | 2.14933359 |
87 | Increased CSF protein (HP:0002922) | 2.12427674 |
88 | Colitis (HP:0002583) | 2.12240313 |
89 | Dementia (HP:0000726) | 2.11360533 |
90 | Abnormality of the periventricular white matter (HP:0002518) | 2.10745004 |
91 | Progressive visual loss (HP:0000529) | 2.08876410 |
92 | Joint hemorrhage (HP:0005261) | 2.08004789 |
93 | Agnosia (HP:0010524) | 2.07982408 |
94 | Eosinophilia (HP:0001880) | 2.06647109 |
95 | Keratoconjunctivitis (HP:0001096) | 2.05524751 |
96 | Memory impairment (HP:0002354) | 2.05496658 |
97 | Porencephaly (HP:0002132) | 2.05106160 |
98 | Petechiae (HP:0000967) | 2.03241712 |
99 | Progressive neurologic deterioration (HP:0002344) | 2.02655684 |
100 | Osteolytic defects of the hand bones (HP:0009699) | 2.01720192 |
101 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01720192 |
102 | Pulmonary embolism (HP:0002204) | 1.99070928 |
103 | Abnormality of the prostate (HP:0008775) | 1.97691064 |
104 | Xanthomatosis (HP:0000991) | 1.96105573 |
105 | Sepsis (HP:0100806) | 1.94440085 |
106 | Arthralgia (HP:0002829) | 1.93372442 |
107 | Abnormality of the pleura (HP:0002103) | 1.92659574 |
108 | Abnormality of the pericardium (HP:0001697) | 1.91939865 |
109 | Inappropriate behavior (HP:0000719) | 1.91508554 |
110 | Vertebral compression fractures (HP:0002953) | 1.91387360 |
111 | Spontaneous hematomas (HP:0007420) | 1.91327193 |
112 | Personality changes (HP:0000751) | 1.89172799 |
113 | Amyloidosis (HP:0011034) | 1.88798891 |
114 | Gastrointestinal stroma tumor (HP:0100723) | 1.88665727 |
115 | Abnormality of iron homeostasis (HP:0011031) | 1.88138338 |
116 | Inflammation of the large intestine (HP:0002037) | 1.85612090 |
117 | Esophageal neoplasm (HP:0100751) | 1.85244939 |
118 | Neoplasm of head and neck (HP:0012288) | 1.85244939 |
119 | Upper motor neuron abnormality (HP:0002127) | 1.84732388 |
120 | Skin ulcer (HP:0200042) | 1.84086093 |
121 | Global brain atrophy (HP:0002283) | 1.84063653 |
122 | Restrictive lung disease (HP:0002091) | 1.83218367 |
123 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.83093043 |
124 | Vertigo (HP:0002321) | 1.83028370 |
125 | Frequent falls (HP:0002359) | 1.82805387 |
126 | Nasal polyposis (HP:0100582) | 1.81585090 |
127 | Abnormality of binocular vision (HP:0011514) | 1.80021369 |
128 | Diplopia (HP:0000651) | 1.80021369 |
129 | Increased IgE level (HP:0003212) | 1.79570590 |
130 | Chest pain (HP:0100749) | 1.79312768 |
131 | Cerebral aneurysm (HP:0004944) | 1.79279782 |
132 | Retinal atrophy (HP:0001105) | 1.77680562 |
133 | Peripheral demyelination (HP:0011096) | 1.77636001 |
134 | Polyneuropathy (HP:0001271) | 1.76292929 |
135 | Acne (HP:0001061) | 1.74267299 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.91196273 |
2 | MAP3K14 | 4.84755967 |
3 | TYK2 | 3.72826646 |
4 | IRAK4 | 3.67591118 |
5 | TBK1 | 3.62810397 |
6 | BLK | 3.59281474 |
7 | IRAK3 | 3.49976662 |
8 | PBK | 2.99016803 |
9 | IKBKE | 2.93796658 |
10 | MAP4K1 | 2.55415749 |
11 | IKBKB | 2.52262629 |
12 | JAK3 | 2.41058650 |
13 | PRPF4B | 2.29586480 |
14 | MAP3K13 | 2.26580060 |
15 | JAK1 | 2.26547307 |
16 | KIT | 2.09688101 |
17 | ERN1 | 1.89860038 |
18 | DDR2 | 1.85539036 |
19 | TXK | 1.73770830 |
20 | TNK2 | 1.69726010 |
21 | CHUK | 1.69314630 |
22 | CDC42BPA | 1.59282293 |
23 | PIM2 | 1.58260738 |
24 | CSK | 1.57585399 |
25 | TAOK3 | 1.48403661 |
26 | SYK | 1.47585445 |
27 | CSF1R | 1.43303986 |
28 | HCK | 1.33729397 |
29 | MAP3K3 | 1.33444341 |
30 | ZAP70 | 1.30011953 |
31 | FGR | 1.23057756 |
32 | LYN | 1.19635834 |
33 | MARK3 | 1.16065594 |
34 | JAK2 | 1.15393679 |
35 | NEK9 | 1.14013905 |
36 | MATK | 1.13273267 |
37 | TAOK2 | 1.10235348 |
38 | LCK | 1.09411762 |
39 | MAPK12 | 1.05787947 |
40 | BTK | 1.05464062 |
41 | TYRO3 | 1.00075590 |
42 | EPHB1 | 0.99274624 |
43 | BMPR2 | 0.98962550 |
44 | TAOK1 | 0.97484868 |
45 | PIM1 | 0.97073533 |
46 | FES | 0.95999940 |
47 | RPS6KA4 | 0.94788415 |
48 | STK4 | 0.94032823 |
49 | MARK2 | 0.92161786 |
50 | MAPK7 | 0.91407460 |
51 | ABL2 | 0.91338219 |
52 | YES1 | 0.89170133 |
53 | TGFBR2 | 0.87934646 |
54 | IRAK2 | 0.81820668 |
55 | BMX | 0.79244902 |
56 | SIK2 | 0.77825555 |
57 | EIF2AK2 | 0.77138007 |
58 | TEC | 0.76626034 |
59 | MAP3K5 | 0.76124494 |
60 | GRK7 | 0.74644636 |
61 | NME2 | 0.74472060 |
62 | IRAK1 | 0.73365624 |
63 | SIK3 | 0.71802702 |
64 | MAP2K6 | 0.71555297 |
65 | EGFR | 0.70754359 |
66 | FGFR3 | 0.70471902 |
67 | MST1R | 0.70346938 |
68 | STK10 | 0.69315297 |
69 | CAMKK2 | 0.68577029 |
70 | PRKCD | 0.68342831 |
71 | TRPM7 | 0.67802371 |
72 | TRIB3 | 0.66724318 |
73 | ABL1 | 0.66646769 |
74 | CLK1 | 0.64910361 |
75 | PTK6 | 0.63663542 |
76 | CAMK1D | 0.63165677 |
77 | DAPK2 | 0.62457604 |
78 | MST4 | 0.62380174 |
79 | NTRK3 | 0.60924006 |
80 | RIPK1 | 0.60156487 |
81 | SGK3 | 0.59923064 |
82 | MUSK | 0.58390367 |
83 | PDGFRA | 0.58315956 |
84 | MAP3K10 | 0.56573259 |
85 | PIK3CG | 0.55226524 |
86 | MAPK4 | 0.54024801 |
87 | CAMKK1 | 0.53985722 |
88 | BMPR1B | 0.53461309 |
89 | KSR2 | 0.52472104 |
90 | FGFR4 | 0.50614180 |
91 | MAP2K3 | 0.49997409 |
92 | STK3 | 0.49830926 |
93 | ARAF | 0.49205289 |
94 | TTN | 0.48806453 |
95 | ROCK2 | 0.48384065 |
96 | ERBB3 | 0.47368286 |
97 | PRKD2 | 0.46126112 |
98 | NTRK2 | 0.46045743 |
99 | SGK2 | 0.45830432 |
100 | PRKCQ | 0.45467099 |
101 | RET | 0.42412923 |
102 | MAP3K6 | 0.42042027 |
103 | HIPK2 | 0.41471746 |
104 | PRKD1 | 0.41426094 |
105 | CDK6 | 0.40129852 |
106 | MAP3K7 | 0.39975580 |
107 | CAMK2G | 0.39487563 |
108 | PRKAA2 | 0.38438874 |
109 | FYN | 0.37591237 |
110 | PDK2 | 0.37047772 |
111 | PDPK1 | 0.36432214 |
112 | MAPKAPK2 | 0.36308593 |
113 | DMPK | 0.34987491 |
114 | PDK1 | 0.34776810 |
115 | RPS6KA6 | 0.34640200 |
116 | DAPK3 | 0.34111861 |
117 | EPHA3 | 0.33918014 |
118 | PRKG2 | 0.32921045 |
119 | PKN1 | 0.30562578 |
120 | LRRK2 | 0.30124372 |
121 | ITK | 0.29643036 |
122 | CDK12 | 0.28858654 |
123 | MAP3K11 | 0.28634825 |
124 | SCYL2 | 0.27378140 |
125 | RPS6KA2 | 0.26770772 |
126 | ADRBK2 | 0.25351910 |
127 | MOS | 0.24009118 |
128 | CAMK1G | 0.23293115 |
129 | IGF1R | 0.22507524 |
130 | PDGFRB | 0.22130541 |
131 | RPS6KL1 | 0.20154489 |
132 | RPS6KC1 | 0.20154489 |
133 | PLK2 | 0.19826585 |
134 | MAP3K1 | 0.18780552 |
135 | NUAK1 | 0.16322525 |
136 | ERBB4 | 0.16250607 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.49608549 |
2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.05266770 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.01083204 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.96745779 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.72804665 |
6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.59858126 |
7 | Legionellosis_Homo sapiens_hsa05134 | 2.57969938 |
8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.54310573 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.52934259 |
10 | Pertussis_Homo sapiens_hsa05133 | 2.50964939 |
11 | Allograft rejection_Homo sapiens_hsa05330 | 2.48996697 |
12 | Tuberculosis_Homo sapiens_hsa05152 | 2.35864960 |
13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.28675099 |
14 | Malaria_Homo sapiens_hsa05144 | 2.16913795 |
15 | Measles_Homo sapiens_hsa05162 | 2.16265594 |
16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.16230398 |
17 | Influenza A_Homo sapiens_hsa05164 | 2.03460105 |
18 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.02681504 |
19 | Lysosome_Homo sapiens_hsa04142 | 2.00984999 |
20 | Asthma_Homo sapiens_hsa05310 | 1.91357209 |
21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87082527 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.80165288 |
23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.79908701 |
24 | Phagosome_Homo sapiens_hsa04145 | 1.75137827 |
25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74844802 |
26 | Salmonella infection_Homo sapiens_hsa05132 | 1.70507586 |
27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.70057334 |
28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64822260 |
29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.60306283 |
30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56680296 |
31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49665356 |
32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46552422 |
33 | Apoptosis_Homo sapiens_hsa04210 | 1.41283884 |
34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40782711 |
35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36921424 |
36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33508383 |
37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33197310 |
38 | Shigellosis_Homo sapiens_hsa05131 | 1.28744495 |
39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26930220 |
40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24826116 |
41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21328949 |
42 | Hepatitis C_Homo sapiens_hsa05160 | 1.19250010 |
43 | Hepatitis B_Homo sapiens_hsa05161 | 1.13312458 |
44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09339220 |
45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.06612920 |
46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00820322 |
47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98775615 |
48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94625517 |
49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.94393485 |
50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89533498 |
51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.87207907 |
52 | Amoebiasis_Homo sapiens_hsa05146 | 0.85640628 |
53 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83019132 |
54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81487701 |
55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80065223 |
56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76155510 |
57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75953377 |
58 | Prion diseases_Homo sapiens_hsa05020 | 0.73314453 |
59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71950015 |
60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71380642 |
61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68631070 |
62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67755237 |
63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67642453 |
64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67552154 |
65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67383290 |
66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66257421 |
67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62823841 |
68 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62242542 |
69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61358447 |
70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61239714 |
71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59822199 |
72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59598853 |
73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56979109 |
74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56807258 |
75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54586662 |
76 | Platelet activation_Homo sapiens_hsa04611 | 0.53543269 |
77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50428351 |
78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50106132 |
79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49588616 |
80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48342081 |
81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44920288 |
82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43531775 |
83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43416144 |
84 | Renin secretion_Homo sapiens_hsa04924 | 0.42735557 |
85 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.42600508 |
86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41980252 |
87 | Bile secretion_Homo sapiens_hsa04976 | 0.39518690 |
88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38380280 |
89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38339674 |
90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38327912 |
91 | Insulin resistance_Homo sapiens_hsa04931 | 0.38134420 |
92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36270354 |
93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35795054 |
94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35430787 |
95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33840724 |
96 | Mineral absorption_Homo sapiens_hsa04978 | 0.32436555 |
97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31731268 |
98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31725327 |
99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28596200 |
100 | Bladder cancer_Homo sapiens_hsa05219 | 0.27919621 |
101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27666434 |
102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27612542 |
103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27141784 |
104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.26404069 |
105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25980405 |
106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25183315 |
107 | Endocytosis_Homo sapiens_hsa04144 | 0.24242846 |
108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23180961 |
109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21761451 |
110 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.21022472 |
111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20970668 |
112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.18269245 |
113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16993303 |
114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.12561802 |
115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10425511 |
116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10267365 |
117 | ABC transporters_Homo sapiens_hsa02010 | 0.10127235 |
118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.09489277 |
119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.09227799 |
120 | Prostate cancer_Homo sapiens_hsa05215 | 0.08438627 |